~~<i id='69FE92AFAA'><strike id='69FE92AFAA'><tt id='69FE92AFAA'><pre id='69FE92AFAA'></pre></tt></strike></i>~~

Home» knowledge» hotspot

hotspot

author：leisure time 2025-09-28 14:32:11 Page View：2978

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Eli Lilly’s Mounjaro succeeds in second weight
Next article： Drug repurposing or repositioning? The language matters

knowledge

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Mom launches Girl Scout troop for LGBTQ youth in Texas

2:16AnewGirlScouttroopspecificallyforLGBTQ+youthhaskickedoffintheFortWorth,Texasarea.Here,someofthen

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Biden administration plans revamp of organ transplant system

SurgicalinstrumentsandsupplieslayonatableduringakidneytransplantsurgeryatMedStarGeorgetownUniversity

WSS

hotspot

hotspot

explore

knowledge

Biden administration plans revamp of organ transplant system